VG

Venkateswara Gantepalli Rao

Active Director Director DIN 02142983
DIN 02142983 First appointment Oct 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 4 historical roles
Total affiliations 8 Since Oct 2005
Shareholding value •••• Premium profile

About Venkateswara Gantepalli Rao

Data last updated:

Venkateswara Gantepalli Rao is a Director at Srv Biosciences Private Limited (since 2009), Director at Reca Labs Private Limited (since 2025) and Director at Rockville Pharma Sciences Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Srv Biosciences Private Limited at ₹10.41 Cr (FY 2025). Earlier, Venkateswara Gantepalli Rao was a Director at Integrin Genomics Private Limited (2005–2008) and Director at Integrin Lifesciences Private Limited (2007–2008) and 2 more.

DIN 02142983
Primary Designation Director
Industry Pharma
First Appointment 17 Oct 2005
Oldest Company Age 17 yrs
Largest company Srv Biosciences Private Limited · ₹10.41 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srv Biosciences Private Limited U73100TG2009PTC063847
Director01 Jun 20092009₹10.41 Cr (FY 2025)Active
Reca Labs Private Limited U21001TS2025PTC204954
Director10 Oct 20252025Active
Director20 Jun 20252025Active
Director03 Aug 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Integrin Genomics Private Limited U24239TG2005PTC047796
Director17 Oct 20052005Strike Off
Director31 Jan 20072007₹92.04 Cr (FY 2025)Active
Director06 Dec 20122012Strike Off
Auro Nutrimin Private Limited U74900TN2010PTC077976
Director24 Jul 20132010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rajdheer Biopharmaceuticals Private Limited
Integrin Remedies India Private Limited
Srv Biosciences Private Limited
Auro Nutrimin Private Limited
Premium access

Shareholding and investment profile for Venkateswara Gantepalli Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkateswara Gantepalli Rao

Venkateswara Gantepalli Rao currently holds 4 directorships: Srv Biosciences Private Limited (Director, since 01 Jun 2009, revenue ₹10.41 Cr (FY 2025)); Reca Labs Private Limited (Director, since 10 Oct 2025); Rockville Pharma Sciences Private Limited (Director, since 20 Jun 2025); Rajdheer Biopharmaceuticals Private Limited (Director, since 03 Aug 2020).

Venkateswara Gantepalli Rao was first appointed on 17 Oct 2005 as Director at Integrin Genomics Private Limited. The most recent appointment on record is 10 Oct 2025 at Reca Labs Private Limited.

Venkateswara Gantepalli Rao held 4 earlier board appointments: Integrin Genomics Private Limited (Director, 17 Oct 2005 to 12 Apr 2008); Integrin Lifesciences Private Limited (Director, 31 Jan 2007 to 24 Apr 2008); Integrin Remedies India Private Limited (Director, from 06 Dec 2012); Auro Nutrimin Private Limited (Director, from 24 Jul 2013).

The current boards of Venkateswara Gantepalli Rao's companies include Aluru Sree Pallavi (Srv Biosciences Private Limited), Ravichandra Ramagiri (Reca Labs Private Limited), Kishan Gunda (Rockville Pharma Sciences Private Limited), Sailaja Muddasani (Rockville Pharma Sciences Private Limited), Satya Narayana Reddy Mandala (Rockville Pharma Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available